Caylent Renews Strategic Collaboration Agreement with AWS to Deliver Industry-Specific GenAI Solutions
NEW YORK, July 16, 2025 /PRNewswire/ -- Caylent, an Amazon Web Services (AWS) Premier Tier Services Partner, today announced a renewed strategic collaboration agreement (SCA) with AWS. The agreement expands investment in AI and industry-specific solutions to accelerate enterprise cloud adoption and generative AI (GenAI) enablement across high-growth verticals including: healthcare and life sciences, financial services, media and entertainment, sports, Software as a Service (SaaS) and Independent Software Vendors (ISVs), travel and hospitality, energy, automotive and manufacturing, education technology and more.
As part of this agreement, Caylent is launching 16 new industry-tailored GenAI solutions and significantly growing its industry and AI-focused teams with the creation of new Industry Principal Strategists. These domain experts understand the unique regulatory, operational, and data challenges of each vertical and will guide customers through complex modernization with tailored roadmaps and measurable outcomes.
The first four GenAI solutions launching are:
Intelligent Document Processing for Financial Services – Transforms financial documents into actionable insights with AI pipelines that automate intake, extraction, and regulatory compliance.
Video Understanding for Media & Entertainment – Transforms video into strategic insights with AI that analyzes visuals, audio, and text to drive personalization, engagement, and monetization.
Clinical Trial Design Optimizer – Brings precision and speed to trial design by integrating real-world data, AI insights, and regulatory precedent. Cuts trial execution costs 10-20% and accelerates overall development timelines by 5-10%
Clinical Document Writer – Reduces regulatory submission documentation time by 40% and costs by 50% by automating clinical writing with AI-powered quality checks and integrated data sources.
"Partnering with Caylent was instrumental in bringing our vision for the Trial Intelligence Coordinator to life. Their deep understanding of clinical research workflows, paired with their AI expertise and deep command of AWS services like Amazon Bedrock and Amazon Comprehend Medical, allowed us to build a GenAI co-pilot that transforms how imaging data is accessed, queried, and utilized," said Susan Wood, PhD, CEO at VIDA Diagnostics Inc, "With Caylent's guidance, we are now on a path to a future-ready solution that delivers real-time imaging insights, enhances collaboration across our global research teams, and sets a new bar for improving patient outcomes and therapeutic effectiveness."
To expedite AI readiness, Caylent Accelerate™, the company's unique AI-powered delivery approach, unlocks previously impossible transformations and helps companies move faster, reduce costs, and create the IP they need to lead in their industries. Caylent Accelerate automates complex tasks like database migration, code translation, and compliance validation, reducing technical debt and helping enterprises build secure, scalable, AI-ready cloud environments.
"As an all-in AWS Premier Tier Services Partner, we're proud to be launching new, purpose-built GenAI solutions across high-growth industries that solve real-world problems," said Caylent President and Chief Revenue Officer Val Henderson. "By adding experienced industry principals and leaders to our team, we are better equipped to guide customers through complex modernization with tailored roadmaps and measurable outcomes. This is just the beginning as we look to expand our smart solution offerings into even more industries in the future."
Learn more about each solution at the links below, or visit Caylent at booth #552 at today's AWS Summit New York City.
Intelligent Document Processing for Financial Services: https://caylent.com/catalysts/intelligent-document-processing
Video Understanding for Media & Entertainment: www.caylent.com/catalysts/video-understanding
Clinical Trial Design Optimizer: https://caylent.com/catalysts/clinical-trial-design-optimizer
Clinical Document Writer: https://caylent.com/catalysts/clinical-document-writer
About CaylentAs an AWS Premier Tier Services Partner, Caylent is shaping the future where AI transforms industries responsibly and with excellence. We help companies build the solutions they need to succeed in today's market while enabling organizational evolution to thrive in a rapidly changing technology landscape. Our AI-enabled delivery methodology combined with our deep AWS experience turns our customers' ideas into impact, faster.
Caylent's achievements include being named AWS Migration Consulting Partner of the Year, GenAI Industry Solution Partner of the Year, and Industry Partner of the Year - Financial Services in 2024, Application Modernization Partner of the Year in 2023, AWS Innovation Partner of the Year in 2022, and AWS Rising Star Partner of the Year in 2021. Caylent's services include migrations, modernization, custom software development and generative AI. Learn more at https://caylent.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/caylent-renews-strategic-collaboration-agreement-with-aws-to-deliver-industry-specific-genai-solutions-302506128.html
SOURCE Caylent
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
13 hours ago
- Business Upturn
LambdaTest Unveils Media Injection for Real Device Testing
Business Wire India LambdaTest, a unified agentic AI and cloud engineering platform, has launched Video Injection capability in Media Injection for real device testing, bringing powerful support for testing camera and video-based app functionalities at scale. This new capability empowers developers and QA teams to simulate image and video capture scenarios on real Android and iOS devices, unlocking comprehensive validation for camera-driven app experiences. With Media Injection, users can test key workflows like QR code and barcode scanning, digital check processing, real-time video streaming, and photo or video upload features, directly on physical devices. This is made possible through LambdaTest's proprietary Sensor Instrumentation technology, which seamlessly injects simulated media into the app's camera interface, bypassing the need for physical camera use while ensuring realistic results. Media Injection supports a wide range of commonly used camera APIs and integrates effortlessly with existing LambdaTest environments. With compatibility across more than 10,000 real devices, the feature ensures unparalleled coverage and accuracy for mission-critical camera workflows. 'Camera functionality is at the heart of many modern apps, whether it's mobile banking, streaming, or shopping,' said Jay Singh, Co-Founder at LambdaTest. 'With Media Injection, we're removing the guesswork from camera testing and giving teams the power to validate these flows with real precision and scale.' Video Injection under Media Injection is now available for all users running app tests on real devices through LambdaTest's cloud platform. For more information, please visit About LambdaTest LambdaTest is a GenAI-powered Quality Engineering Platform that empowers teams to test intelligently, smarter, and ship faster. Built for scale, it offers a full-stack testing cloud with 10K+ real devices and 3,000+ browsers. With AI-native test management, MCP servers, and agent-based automation, LambdaTest supports Selenium, Appium, Playwright, and all major frameworks. AI Agents like HyperExecute and KaneAI bring the power of AI and cloud into your software testing workflow, enabling seamless automation testing with 120+ integrations. LambdaTest Agents accelerate your testing throughout the entire SDLC, from test planning and authoring to automation, infrastructure, execution, RCA, and reporting. For more information, please visit View source version on Disclaimer: The above press release comes to you under an arrangement with Business Wire India. Business Upturn take no editorial responsibility for the same. Ahmedabad Plane Crash
Yahoo
15 hours ago
- Yahoo
Sendbird, AWS Announce 3-Year Strategic AI Collaboration
Inc. (NASDAQ:AMZN) is one of the best high-volume stocks to invest in. On August 12, Sendbird, an AI communications platform, announced a 3-year strategic collaboration with Amazon Web Services/AWS. The agreement allows adoption of agentic AI by expanding Sendbird's AI agent capabilities, deepening technical integrations with AWS services, and accelerating joint go-to-market efforts. As part of the collaboration, Sendbird is a launch partner for the new AI Agents and Tools category on AWS Marketplace, where it is now offering its AI agent solution. According to a prediction from Gartner, agentic AI will autonomously resolve 80% of customer service issues by 2029. Sendbird, which currently powers over 7 billion conversations every month, is already showing the potential of this technology. A customer entering an internet retail store, illustrating the convenience of online shopping. The partnership will involve a strategic go-to-market plan to target key industries such as travel, on-demand services, and retail. The collaboration aims to help businesses deliver more proactive and intelligent customer support at scale, driving down operational costs and meeting evolving consumer expectations. Inc. (NASDAQ:AMZN) engages in the retail sale of consumer products, advertising, and subscription services through online and physical stores in North America and internationally. While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
20 hours ago
- Associated Press
DermRays Celebrates 13 Years of Skincare Innovation with Exclusive Anniversary Sale and Groundbreaking 1450nm Laser Device for 2026
PLEASANTON, Calif., Aug. 15, 2025 /PRNewswire/ -- DermRays, a pioneer in at-home skincare technology, marks its 13th anniversary with a celebration of its best-selling devices and a sneak peek at its upcoming 1450nm laser skincare tool, slated for launch in early 2026. This milestone underscores the brands commitment to merging cutting-edge science with accessible beauty solutions. Anniversary Spotlight: Award-Winning Skincare Heroes To thank customers for their trust, DermRays is offering limited-time discounts on three transformative devices designed to rejuvenate skin at home: 1. DermRays Revive The first and only at-home laser with ultra-high energy for collagen regeneration. Ideal for reducing fine lines and boosting collagen, its a clinic-grade tool for a fraction of the cost. Revive uses cutting-edge 1064nm laser technology, the same as that employed by leading salon brands. 2. FusionGlow Multi-Functional Microcurrent Toning Device Beyond Microcurrent: 5 Skincare Technologies You Need. Comprehensive Skin Revitalization: Brighten, Hydrate, Rejuvenate. Achieve radiant, firm skin in 14 days with clinically visible results backed by SGS. 3. LED Light Therapy Silicone Mask Your daily skincare companion: blue, red, infrared, and mixed light for every need. Only 15 minutes a day for youthful and radiant skin. 'For 13 years, we've empowered users to take control of their skincare routines with safe, effective technology,' says Dr. Yang Lin, Brand Director at DermRays. 'Our anniversary sale is a tribute to our community-and just the beginning of whats next.' 4. The Future: 1450nm Laser Skincare Device DermRays is set to revolutionize at-home treatments again with its 1450nm laser device (expected Q1 2026). It stimulates natural collagen production to smooth fine lines, restore firmness, and reverse signs of aging. This tool will expand the brands professional-grade offerings, bridging the gap between spa treatments and home care. Join the Celebration From August 1-31, 2025, enjoy exclusive anniversary bundles and discounts on DermRays bestselling devices. Follow @DermRays on social media for giveaways and live demos. About DermRays Since 2011, DermRays has combined dermatological research with accessible technology, offering FDA/CE/UKCA-cleared, non-invasive devices for radiant, youthful skin at home. View original content to download multimedia: SOURCE DermRays
